BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 17218854)

  • 1. Ductal carcinoma in situ: a review of recent advances.
    Tang P; Hajdu SI; Lyman GH
    Curr Opin Obstet Gynecol; 2007 Feb; 19(1):63-7. PubMed ID: 17218854
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Actual management of ductal carcinoma in situ of the breast.
    Maass N; Alkasi O; Bauer M; Jonat W; Souchon R; Meinhold-Heerlein I
    Arch Gynecol Obstet; 2009 Nov; 280(5):699-705. PubMed ID: 19259692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ductal carcinoma in situ of the breast: our experience.
    Ruggiero R; Procaccini E; Sanguinetti A; Cremone C; Gili S; Docimo G; Docimo L; Sparavigna L; Gubitosi A; Parmeggiani D; Avenia N
    G Chir; 2009 Mar; 30(3):121-4. PubMed ID: 19351465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent advances and current controversies in the management of DCIS of the breast.
    Sakorafas GH; Farley DR; Peros G
    Cancer Treat Rev; 2008 Oct; 34(6):483-97. PubMed ID: 18490111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Occult "micrometastases" in ductal carcinoma in situ: investigative implications for sentinel lymph node biopsy.
    Weaver DL
    Cancer; 2003 Nov; 98(10):2083-7. PubMed ID: 14601075
    [No Abstract]   [Full Text] [Related]  

  • 6. Re: Trends in the treatment of ductal carcinoma in situ of the breast.
    Zorbas H; Luxford K; Evans A; Villanueva EV
    J Natl Cancer Inst; 2004 Aug; 96(16):1258; author reply 1259-60. PubMed ID: 15316063
    [No Abstract]   [Full Text] [Related]  

  • 7. Is excision alone adequate treatment for low-risk ductal carcinoma-in-situ of the breast?
    Solin LJ
    J Clin Oncol; 2006 Mar; 24(7):1017-9. PubMed ID: 16461780
    [No Abstract]   [Full Text] [Related]  

  • 8. [Ductal carcinoma in situ of the breast].
    Procaccini E; Ruggiero R; Docimo G; Iovino F; Procaccini F; Gili S; Lo Schiavo F
    G Chir; 2006; 27(1-2):40-4. PubMed ID: 16608632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 259 Patients with DCIS of the breast applying USC/Van Nuys prognostic index: a retrospective review with long term follow up.
    Di Saverio S; Catena F; Santini D; Ansaloni L; Fogacci T; Mignani S; Leone A; Gazzotti F; Gagliardi S; De Cataldis A; Taffurelli M
    Breast Cancer Res Treat; 2008 Jun; 109(3):405-16. PubMed ID: 17687650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biological variables and prognosis of DCIS.
    van de Vijver MJ
    Breast; 2005 Dec; 14(6):509-19. PubMed ID: 16246564
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical outcome after selective treatment of patients diagnosed with ductal carcinoma in situ of the breast.
    Meijnen P; Oldenburg HS; Peterse JL; Bartelink H; Rutgers EJ
    Ann Surg Oncol; 2008 Jan; 15(1):235-43. PubMed ID: 17987342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Does molecular biology play any role in ductal carcinoma in situ?].
    Sakr RA
    Gynecol Obstet Fertil; 2013 Jan; 41(1):45-53. PubMed ID: 23286959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ductal carcinoma in situ (DCIS) of the breast--a therapeutic dilemma.
    van Dongen JA; Bartelink H; Fentiman IS; Peterse JL
    Eur J Surg Oncol; 1987 Apr; 13(2):123-5. PubMed ID: 3030824
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The molecular journey from ductal carcinoma in situ to invasive breast cancer.
    Wiechmann L; Kuerer HM
    Cancer; 2008 May; 112(10):2130-42. PubMed ID: 18383519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Residual ductal carcinoma in situ in patients with complete eradication of invasive breast cancer after neoadjuvant chemotherapy does not adversely affect patient outcome.
    Mazouni C; Peintinger F; Wan-Kau S; Andre F; Gonzalez-Angulo AM; Symmans WF; Meric-Bernstam F; Valero V; Hortobagyi GN; Pusztai L
    J Clin Oncol; 2007 Jul; 25(19):2650-5. PubMed ID: 17602071
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current management of DCIS: a review.
    Patani N; Cutuli B; Mokbel K
    Breast Cancer Res Treat; 2008 Sep; 111(1):1-10. PubMed ID: 17902049
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ductal carcinoma in situ of the breast: the importance of morphologic and molecular interactions.
    Mardekian SK; Bombonati A; Palazzo JP
    Hum Pathol; 2016 Mar; 49():114-23. PubMed ID: 26826418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term cosmesis after lumpectomy and brachytherapy in the management of carcinoma of the previously irradiated breast.
    Trombetta M; Julian TB; Werts DE; McWilliams W; Kim Y; Miften M; Parda D
    Am J Clin Oncol; 2009 Jun; 32(3):314-8. PubMed ID: 19451803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Re: Trends in the treatment of ductal carcinoma in situ of the breast.
    Schwartz GF; Lagios MD; Silverstein MJ
    J Natl Cancer Inst; 2004 Aug; 96(16):1258-9; author reply 1259-60. PubMed ID: 15316064
    [No Abstract]   [Full Text] [Related]  

  • 20. [Combined surgery and radiotherapy in the treatment of ductal carcinoma in situ of the breast: preliminary results of the Hungarian multicenter prospective randomised study].
    Polgár C; Orosz Z; Kahán Z; Gábor G; Jani N; Cserni G; Hadijev J; Kulka J; Sulyok Z; Boross G; Lázár G; László Z; Diczházi C; Udvarhelyi N; Szabó E; Péntek Z; Major T; Fodor J
    Magy Onkol; 2008 Sep; 52(3):269-77. PubMed ID: 18845497
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.